DM
MRTX

Deerfield Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Deerfield Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-270,000
Closed -$22.2M – 137
2022
Q1 		$22.2M Buy
270,000
+182,000
+207% +$18.6M 0.5% 47
2021
Q4 		$12.9M Buy
+88,000
New +$13.7M 0.27% 75
2020
Q3 		– Sell
-179,885
Closed -$20.5M – 117
2020
Q2 		$20.5M Sell
179,885
-62,315
-26% -$6.04M 0.6% 57
2020
Q1 		$18.6M Buy
242,200
+68,200
+39% +$6.12M 0.59% 53
2019
Q4 		$22.4M Sell
174,000
-59,000
-25% -$5.69M 0.72% 45
2019
Q3 		$18.2M Sell
233,000
-31,600
-12% -$2.97M 0.74% 43
2019
Q2 		$27.3M Buy
264,600
+12,400
+5% +$965K 0.98% 33
2019
Q1 		$18.5M Sell
252,200
-622,286
-71% -$42.3M 0.71% 45
2018
Q4 		$37.1M Buy
874,486
+33,575
+4% +$1.34M 1.48% 24
2018
Q3 		$39.6M Sell
840,911
-459,454
-35% -$25.6M 1.42% 26
2018
Q2 		$64.1M Buy
1,300,365
+1,103,365
+560% +$41.7M 2.25% 5
2018
Q1 		$6.05M Sell
197,000
-178,000
-47% -$4.94M 0.21% 97
2017
Q4 		$6.84M Buy
+375,000
New +$5.82M 0.27% 78
2015
Q4 		– Sell
-110,049
Closed -$3.79M – 129
2015
Q3 		$3.79M Sell
110,049
-287,611
-72% -$8.69M 0.15% 99
2015
Q2 		$12.5M Buy
397,660
+364,748
+1,108% +$10.7M 0.42% 67
2015
Q1 		$965K Buy
+32,912
New +$772K 0.03% 112

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Deerfield Management's MRTX Position: Q2 2022 in Review

Deerfield Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2022, closing a stake of 270,000 shares — an estimated $22.2M sold.

Deerfield Management first reported a position in MRTX in Q1 2015 and held it in 16 quarters. The position peaked at $64.1M in Q2 2018. 230 funds tracked by Wall St. Rank hold MRTX as of Q2 2022.

  • Deerfield Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Deerfield Management sold 270,000 Mirati Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $22.2M.
  • Deerfield Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2015 and held it in 16 quarters.
  • Deerfield Management's Mirati Therapeutics, Inc. Common Stock position peaked at $64.1M in Q2 2018.
  • 230 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Deerfield Management's 13F filing for Q2 2022, filed 15 Aug 2022.